Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Scott

Showing results (331-340 of 337) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 337 results.
Pharmacology & Therapeutics|May 5, 2001
Death the Fas way: regulation and pathophysiology of CD95 and its ligandK Sharma, R X Wang, L Y Zhang, et al.
Veterinary Pathology|January 22, 2000
Feline papillomas and papillomavirusesJ P Sundberg, M Van Ranst, R Montali, et al.
Leukemia|March 4, 2015
IL10 receptor is a novel therapeutic target in DLBCLsW Béguelin, S Sawh, N Chambwe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 6, 2016
Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014Y Dargaud, A Pavlova, S Lacroix-Desmazes, et al.
Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.
British Journal of Haematology|November 8, 2024
Long-term follow-up of bulky classic Hodgkin lymphoma managed with ABVD and PET-guided RT demonstrates excellent outcomes in PET-negative casesJ L Kim, D Villa, R P Tonseth, et al.
Mabs|February 18, 2020
10<sup>th</sup> European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsS Tourdot, A Abdolzade-Bavil, J Bessa, et al.
Pageof 34

Showing results (331-340 of 337) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 337 results.
Pharmacology & Therapeutics|May 5, 2001
Death the Fas way: regulation and pathophysiology of CD95 and its ligandK Sharma, R X Wang, L Y Zhang, et al.
Veterinary Pathology|January 22, 2000
Feline papillomas and papillomavirusesJ P Sundberg, M Van Ranst, R Montali, et al.
Leukemia|March 4, 2015
IL10 receptor is a novel therapeutic target in DLBCLsW Béguelin, S Sawh, N Chambwe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 6, 2016
Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014Y Dargaud, A Pavlova, S Lacroix-Desmazes, et al.
Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.
British Journal of Haematology|November 8, 2024
Long-term follow-up of bulky classic Hodgkin lymphoma managed with ABVD and PET-guided RT demonstrates excellent outcomes in PET-negative casesJ L Kim, D Villa, R P Tonseth, et al.
Mabs|February 18, 2020
10<sup>th</sup> European immunogenicity platform open symposium on immunogenicity of biopharmaceuticalsS Tourdot, A Abdolzade-Bavil, J Bessa, et al.
Pageof 34